AC  GenProp2085
DE  Renin-Angiotensin system
TP  SYSTEM
AU  Rawlings ND
TH  1
RN  [1]
RM  10619573  
RT  The renin-angiotensin-aldosterone system: a specific target 
RT  for hypertension management. 
RA  Weir MR; Dzau VJ; 
RL  Am J Hypertens 1999;12:205S-213S.
RN  [2]
RM  11707427  
RT  Evidence that the angiotensin IV (AT(4)) receptor is the 
RT  enzyme insulin-regulated aminopeptidase. 
RA  Albiston AL; McDowall SG; Matsacos D; Sim P; Clune E; 
RA  Mustafa T; Lee J;Mendelsohn FA; Simpson RJ; Connolly LM; 
RA  Chai SY; 
RL  J Biol Chem. 2001;276:48623-48626.
RN  [3]
RM  1653799  
RT  Evidence that prolyl endopeptidase participates in the 
RT  processing of brain angiotensin. 
RA  Welches WR; Santos RA; Chappell MC; Brosnihan KB; Greene LJ; 
RA  Ferrario CM;
RL  J Hypertens 1991;9:631-638.
RN  [4]
RM  26102692  
RT  The role of neprilysin in angiotensin 1-7 formation in the 
RT  kidney. 
RA  Domenig O; Manzel A; Grobe N; Kaltenecker C; Kovarik J; 
RA  Stegbauer J; Gurley SB; Antlanger M; Elased K; Saemann M; 
RA  Linker R; Poglitsch M;
RL  J Hypertens 2015;33 Suppl 1:e114-e115.
RN  [5]
RM  15809376  
RT  G-protein-coupled receptor Mas is a physiological antagonist 
RT  of the angiotensin II type 1 receptor.
RA  Kostenis E; Milligan G; Christopoulos A; Sanchez-Ferrer CF; 
RA  Heringer-Walther S; Sexton PM; Gembardt F; Kellett E; 
RA  Martini L; Vanderheyden P; Schultheiss HP; Walther T;
RL  Circulation 2005;111:1806-1813.
RN  [6]
RM  24760442   
RT  New components of the renin-angiotensin system: alamandine 
RT  and the MAS-related G protein-coupled receptor D.
RA  Etelvino GM; Peluso AA; Santos RA;
RL  Curr Hypertens Rep 2014;16:433.
CC  Blood pressure and hydro-electrolyte balance is regulated by 
CC  the peptide hormone angiotensin, which is secreted as a 
CC  precursor, angiotensinogen, by the kidney. The aspastic
CC  endopeptidase releases the active decapeptide angiotensin I
CC  which is in turn cleaved by the metalloendopeptidase ACE 
CC  (angiotensin-converting enzyme) to generate angiotensin II.
CC  The binding of angiotensin II to its cell-surface receptor 
CC  AT1R brings about vasoconstriction, absorption of sodium in
CC  the kidney and aldosterone secretion, all of which increase
CC  blood pressure and hypertension. Glutamyl aminopeptidase
CC  converts angiotensin II to angiotensin III, which leads to
CC  aldosterone release from the adrenal glands. Aldosterone
CC  is essential for sodium conservation in the kidney, salivary
CC  glands, sweat glands and colon [1]. Membrane alanyl 
CC  aminopeptidase (aminopeptidase N) generates angiotensin IV.
CC  Cystinyl aminopeptidase is the angiotensin IV receptor [2].
CC  Neprilysin and prolyl oligopeptidase generate angiotensin 
CC  1-7 [3,4]. MAS1 is the angiotensin 1-7 receptor and an
CC  antagnoist of AT1R [5]. Alamandine is derived from 
CC  angiotensin 1-7 by decarboxylation or by cleavage of 
CC  angiotensin A by ACE2. Alamandine binds to the Mas-related 
CC  G protein coupled receptor D and induces vasorelaxation [6].
DC  Renin-angiotensin system
DR  KEGG; map04614;
**  Angiotensinogen is related to serpins and is MEROPS I04.953
**  Renin is MEROPS A01.007.
**  Angiotensin-converting enzymes 1 and 2 are MEROPS XM02.001 (complex), M02.001 (ACE domain 1), M02.004 (ACE domain 2) and M02.006 (ACE2).
**  Membrane alanyl aminopeptidase is MEROPS M01.001.
**  Cystinyl aminopeptidase is MEROPS M01.011.
**  Neprilysin is MEROPS M13.001.
**  Prolyl oligopeptidase is MEROPS S09.001.
**  IPR034135 includes renins 1 and 2 (found only in mouse)
**  IPR001548 includes ACE1 and ACE2.
**  IPR000248 includes receptors AT1R and AT2R.
**  The KEGG pathway does not include neprilysin.
**  The KEGG pathway includes other peptidases that are able 
**  to process angiotensin, but many of these are intracellular,
**  such as thimet oligopeptidase and neurolysin, and so the
**  physiological relevance is questionable.
**  Angiotensin A is generated from angiogtensin II by 
**  "mononuclear leukocyte-derived aspartate decarboxylase", 
**  but the sequence of this enzyme has not been identified
**  and I have assumed it is UniProt Q6ZQY3.
--
SN  1
ID  Angiotensinogen
DN  Angiotensinogen
RQ  1
EV  IPR000227; PR00654; sufficient;
EV  IPR000227; PTHR11461:SF13; sufficient;
TG  GO:0002016;
--
SN  2
ID  Renin
DN  Renin (EC 3.4.23.15)
RQ  1
EV  IPR034135; cd05487; sufficient;
TG  GO:0002016;
TG  GO:0004190;
--
SN  3
ID  Angiotensin-converting enzyme
DN  Angiotensin-converting enzyme (EC 3.4.17.23)
RQ  1
EV  IPR001548; PF01401; sufficient;
EV  IPR001548; PR00791; sufficient;
EV  IPR001548; PTHR10514; sufficient;
EV  IPR001548; cd06461; sufficient;
TG  GO:0002016;
TG  GO:0008241;
--
SN  4
ID  Angiotensin II receptor
DN  Angiotensin II receptor
RQ  1
EV  IPR000248; PR00241; sufficient;
TG  GO:0001595;
--
SN  5
ID  Glutamyl aminopeptidase
DN  Glutamyl aminopeptidase (EC 3.4.11.7)
RQ  1
EV  IPR033508; PTHR11533:SF242; sufficient;
TG  GO:0002016;
TG  GO:0070006;
--
SN  6
ID  Aminopeptidase N
DN  Aminopeptidase N (EC 3.4.11.2)
RQ  1
EV  IPR034016; cd09601; sufficient;
TG  GO:0002016;
TG  GO:0070006;
--
SN  7
ID  Cystinyl aminopeptidase
DN  Cystinyl aminopeptidase (EC 3.4.11.3)
RQ  1
EV  IPR034017; PTHR11533:SF42; sufficient;
TG  GO:0001595;
--
SN  8
ID  Neprilysin
DN  Neprilysin (EC 3.4.24.11)
RQ  1
EV  IPR029727; PTHR11733:SF114; sufficient;
TG  GO:0004222;
--
SN  9
ID  Prolyl oligopeptidase
DN  Prolyl oligopeptidase (EC 3.4.21.26)
RQ  1
EV  IPR002470; PR00862; sufficient;
TG  GO:0002016;
TG  GO:0004252;
--
SN  10
ID  Acidic amino acid decarboxylase GADL1
DN  Acidic amino acid decarboxylase GADL1 (EC 4.1.1.11)
RQ  1
EV  IPR039025; PTHR11999:SF95; sufficient;
TG  GO:0004068;
--
SN  11
ID  Proto-oncogene Mas
DN  Proto-oncogene Mas (MAS1)
RQ  1
EV  IPR000820; PR00533; sufficient;
TG  GO:0001595;
--
SN  12
ID  Mas-related G-protein coupled receptor member D
DN  Mas-related G-protein coupled receptor member D
RQ  1
EV  IPR026232; PR02110; sufficient;
EV  IPR026232; cd15108; sufficient;
TG  GO:0001595;
//
